ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

ACAD News and Commentary

Caps

How do you think ACAD will perform against the market?

Add Stock to CAPS Watchlist

All Players

301 Outperform
74 Underperform
 

All-Star Players

58 Outperform
17 Underperform
 

Wall Street

7 Outperform
2 Underperform
 

Top ACAD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

evanation (< 20)
Submitted February 27, 2015

This is a speculative biotech, but is close to getting their first drug out.

TMFBiologyFool (59.75)
Submitted November 27, 2012

No catalyst for awhile. And second phase 3 isn't a sure thing. Placebo effect is hard to beat twice.

ACAD VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ACAD.

Recs

0
Member Avatar Carvski (86.09) Submitted: 7/7/2017 2:25:41 AM : Outperform Start Price: $28.98 ACAD Score: +5.97

Buyout likely in Q3 or Q4. I've been loading up with real money < $30. Also, a Baker Bros. pick. Buy.

Recs

0
Member Avatar MarkBiotech (43.53) Submitted: 4/5/2017 3:48:38 AM : Outperform Start Price: $29.43 ACAD Score: +16.02

Nuplazid is the first drug approved for the treatment of PD psychosis. This market represents a 2-3B peak in sales. If Pimavanserin successfully expands its label to Alzheimer psychosis, Alzheimer agitation, schizo IRAT, then you have a company with unlimited potential.

2nd half of 2016 sales on Nuplazid were encouraging and prompted more confidence in my long position in Acadia. Nuplazid consensus of 90m sales in 2017 seems very conservative. All said and done, Acadia seems to be on the right track to becoming a pharmaceutical powerhouse.

LT Closing limit PT- 100

Recs

0
Member Avatar constructive (99.98) Submitted: 3/3/2017 4:05:27 PM : Underperform Start Price: $4.83 ACAD Score: -573.89

This article does a good job of laying out the bear case: http://seekingalpha.com/article/4015176-acadias-nuplazid-blockbuster-drug-imagined

The market may turn out to be smaller than expected, especially with the black box warning ("Side effects include death"). Most of the market is covered by Medicare, and pricing could be under pressure. Cash burn is also very high.

Leaderboard

Find the members with the highest scoring picks in ACAD.

Score Leader

jamrod02

jamrod02 (66.07) Score: +4,511.21

The Score Leader is the player with the highest score across all their picks in ACAD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jamrod02 66.07 12/20/2010 Outperform 5Y $0.77 +4,617.50% +106.28% +4,511.21 0 Comment
noobtery 50.54 10/28/2010 Outperform 5Y $0.83 +4,275.90% +116.31% +4,159.59 0 Comment
Hornet41 63.39 12/22/2010 Outperform 5Y $0.90 +3,935.11% +104.90% +3,830.21 0 Comment
Ruckwerts 57.08 12/1/2011 Outperform 3Y $0.93 +3,805.38% +106.07% +3,699.31 0 Comment
dsherid2 83.41 11/30/2011 Outperform 1Y $1.03 +3,426.56% +106.95% +3,319.61 0 Comment
Smog79 < 20 8/12/2010 Outperform 3W $1.04 +3,392.31% +136.73% +3,255.58 0 Comment
drmanand 62.37 7/14/2010 Outperform 1Y $1.11 +3,172.66% +135.21% +3,037.45 1 Comment
smallandmidcap 96.88 8/10/2010 Outperform 5Y $1.13 +3,114.16% +129.50% +2,984.66 0 Comment
dmkj50 55.18 10/27/2011 Outperform 5Y $1.17 +3,004.01% +100.98% +2,903.03 0 Comment
cchigga 88.21 1/3/2011 Outperform 5Y $1.19 +2,952.10% +102.91% +2,849.19 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 87.07 8/27/2015 Outperform NS $38.50 -5.66% +30.50% -36.16 0 Comment
TrackJimCramer 84.96 4/14/2015 Outperform 3W $36.81 -1.33% +22.73% -24.06 0 Comment
TrackJimCramer 84.96 3/13/2015 Underperform 3W $34.45 +6.85% +1.78% -5.07 4/14/2015 @ $36.81 0 Comment
TrackCowenandCo 87.84 11/21/2014 Outperform NS $28.78 +26.22% +23.82% +2.40 0 Comment
TrackJimCramer 84.96 9/11/2014 Outperform 3W $27.47 +25.41% +2.76% +22.65 3/13/2015 @ $34.45 0 Comment
TrackJPMorgan 90.52 5/15/2014 Outperform NS $19.85 +82.97% +36.27% +46.70 0 Comment
TrackJimCramer 84.96 10/10/2013 Underperform 3W $23.03 +19.28% +18.40% -0.88 9/11/2014 @ $27.47 0 Comment
TrackJimCramer 84.96 1/22/2013 Outperform 3W $5.67 +306.17% +13.44% +292.73 10/10/2013 @ $23.03 0 Comment
TrackLadenburg < 20 4/30/2012 Outperform NS $1.55 +2,243.23% +83.51% +2,159.72 0 Comment
TrackCitigroup 93.29 9/2/2009 Underperform NS $1.72 +2,011.63% +153.41% -1,858.22 0 Comment
TrackBofASec 96.25 6/17/2008 Underperform NS $4.52 -17.48% -8.41% +9.06 7/8/2008 @ $3.73 0 Comment
TrackZacks < 20 3/6/2008 Outperform 3M $8.74 -70.59% -3.09% -67.50 8/7/2008 @ $2.57 1 Comment
TrackBreanMurray 74.63 11/6/2007 Underperform NS $13.80 +163.19% +78.55% -84.63 0 Comment
TrackLehmanBros < 20 10/9/2007 Outperform NS $16.00 -90.31% -11.19% -79.12 4/17/2012 @ $1.55 0 Comment
TrackDeutscheSec 90.19 8/21/2007 Outperform NS $15.00 +142.13% +87.17% +54.96 0 Comment
TrackJimCramer 84.96 8/16/2007 Underperform 3W $15.21 -62.72% +4.95% +67.67 1/22/2013 @ $5.67 0 Comment
TrackFBRCapitalM 90.18 7/10/2007 Outperform NS $13.65 -66.89% -10.20% -56.68 6/17/2008 @ $4.52 0 Comment
TrackJimCramer 84.96 6/5/2007 Outperform 3W $12.43 +22.37% -7.42% +29.79 8/17/2007 @ $15.21 0 Comment
TrackJMP 84.66 4/9/2007 Outperform NS $15.96 -82.71% -11.60% -71.11 8/6/2008 @ $2.76 0 Comment
TrackRodmanRen < 20 3/23/2007 Outperform NS $13.53 +168.44% +89.71% +78.73 0 Comment
TrackFortisBank < 20 2/23/2007 Outperform NS $7.89 -68.31% -26.12% -42.20 10/2/2008 @ $2.50 0 Comment
TrackNeedham 91.52 12/14/2006 Outperform NS $9.19 -82.54% -6.32% -76.21 3/31/2011 @ $1.61 0 Comment
TrackBofASec 96.25 8/15/2006 Outperform NS $5.74 -21.25% +6.68% -27.93 6/17/2008 @ $4.52 0 Comment
TrackJimCramer 84.96 5/31/2006 Underperform 3W $10.36 +19.98% +20.20% +0.22 6/6/2007 @ $12.43 0 Comment
TrackJimCramer 84.96 3/2/2006 Outperform 3W $14.81 -30.05% -1.48% -28.57 5/31/2006 @ $10.36 0 Comment

Featured Broker Partners